What's New in Screener 18
Running Automated Assay Cascades in the Digital Lab
A Single End-to-End Platform for MAM
Genedata Imagence 3.0 Is Here! See What's New.
AI-powered High Content Screening Analytics with Genedata Imagence 3.0
Flow Cytometry, Automated Analysis and Reporting
Automated Monitoring of Glycosylation in Biopharmaceuticals
Streamlining the Analysis of Compound Combination Screens
Streamlining SARS-CoV-2 Antibody Discovery at Twist Biopharma
Interpretation of Mechanistic Screening Data
Protein Engineering: Bi- and Multi-Specifics, TCRs, and CAR Ts
Merging Automation and Data Management Technology
Integrating Automated and Manual Cell Line Development Workflows
A Novel Data Processing Strategy for Detection of Low-Abundance HCPs
MAM Validation in Biopharma Process Characterization
Using AI for High-Content Phenotypic Characterization
What's New in Genedata Screener 17
Genedata Imagence: A Deep Learning-Based Enterprise Solution
Mosaic SampleBank and Genedata Screener
Genedata Screener for Thermal Shift Assays
Genedata Screener for SPR and BLI
Genedata Screener for Mechanistic Analysis
HT-Electrophysiology Cardiac Liability Assessment
Analyze Multiple APC Plates in One Session
HCS Data Analysis with Genedata Screener
HCS Analysis Workflow at Amgen
Analyze all bioassay data on one single platform
Addressing the Efficacy and Toxicity Challenges of Immuno-Oncology
Target Identification in Triple Negative Breast Cancers
Quality Monitoring of Biotherapeutics by Multi-attribute Methods
Improving the Diagnosis and Therapeutic Outcome of Ovarian Cancer Using Novel Liquid Biopsy Tests
Therapeutic Combinations for Cancer
Novel Methods for Deep Characterization of Biotherapeutics
Unbiased MS-based Characterization of a Stressed mAb
LC-MS Peptide Map Profiling
